Bakhiya N, Arlt VM, Bahn A, Burckhardt G, Phillips DH, Glatt H. 2009. Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy. Toxicology 264:74-79.
Baudoux TE, Pozdzik A, Arlt VM, De Prez EG, Antoine MH, Quellard N, Goujon JM, Nortier JL. 2012. Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy. Kidney Int. 82:1105-1113.
Bi WR, Xu GT, Lv LX, Yang CQ. 2014. The ratio of transforming growth factor-β1/bone morphogenetic protein-7 in the progression of the epithelial-mesenchymal transition contributes to rat liver fibrosis. Genet. Mol. Res. 13:1005-1014.
Boffa JJ, Ronco P. 2007. Strategies to reverse fibrotic lesions of the kidney. Presse Med. 36:1857-1864.
Chen D, Tang Z, Luo C, Chen H, Liu Z. 2012. Clinical and pathological spectrums of aristolochic acid nephropathy. Clin. Nephrol. 78:54-60.
Davies MR, Lund RJ, Hruska KA. 2003. BMP-7 Is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J. Am. Soc. Nephrol. 14:1559-1567.
Debelle FD, Nortier JL, De Prez EG, Garbar CH, Vienne AR, Salmon IJ, Deschodt-Lanckman MM, Vanherweghem JL. 2002. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J. Am. Soc. Nephrol. 13:431-436.
Debelle FD, Nortier JL, Husson CP, De Prez EG, Vienne AR, Rombaut K, Salmon IJ, Deschodt-Lanckman MM, Vanherweghem JL. 2004. The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids. Kidney Int. 66:1815-1825.
Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. 1994. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis. 24:172-180.
Dorai H, Vukicevic S, Sampath TK. 2000. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J. Cell Physiol. 184:37-45.
Dudas PL, Argentieri RL, Farrell FX. 2009. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol. Dial. Transplant. 24:1406-1416.
Eddy AA. 1996. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7:2495-2508.
Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. 1999. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 56:1455-1467.
Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. 2010. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J. Biol. Chem. 285:20202-20212.
Fragiadaki M, Mason RM. 2011. Epithelial-mesenchymal transition in renal fibrosis-evidence for and against. Int. J. Exp. Pathol. 92:143-150.
Gökmen MR, Cosyns JP, Arlt VM, Stiborová M, Phillips DH, Schmeiser HH, Simmonds MS, Cook HT, Vanherweghem JL, Nortier JL, Lord GM. 2013. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann. Intern. Med. 158:469-477.
Grabias BM, Konstantopoulos K. 2014. The physical basis of renal fibrosis: effects of altered hydrodynamic forces on kidney homeostasis. Am. J. Physiol. Renal Physiol. 306:F473-F485.
Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L. 2003. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63:2172-2178.
Hackett TL, Warner SM, Stefanowicz D, Shaheen F, Pechkovsky DV, Murray LA, Argentieri R, Kicic A, Stick SM, Bai TR, Knight DA. 2009. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am. J. Respir. Crit. Care Med. 180:122-133.
Honda E, Park AM, Yoshida K, Tabuchi M, Munakata H. 2013. Myofibroblasts: biochemical and proteomic approaches to fibrosis. Tohoku J. Exp. Med. 230:67-73.
Ikeda Y, JungYO, Kim H, Oda T, López-Guisa J, Maruvada R, Diamond DL, Martin KJ, Wing D, Cai X, Eddy AA. 2004. Exogenous bone morphogenetic protein-7 fails to attenuate renal fibrosis in rats with overload proteinuria. Nephron Exp. Nephrol. 97:e123-e135.
Ivanova L, Butt M, Matsell DG. 2008. Mesenchymal transition in kidney collecting duct epithelial cells. Am. J. Physiol. Renal Physiol. 294:F1238-F1248.
Lebeau C, Debelle FD, Arlt VM, Pozdzik A, De Prez EG, Phillips DH, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL. 2005. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies. Nephrol. Dial. Transplant. 20:2321-2332.
Li Y, Liu Z, Guo X, Shu J, Chen Z, Li L. 2006. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Arch Toxicol. 80:524-532.
Liu Y. 2010. New insights into epithelial-mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 21:212-222.
Luo DD, Phillips A, Fraser D. 2010. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. Am. J. Pathol. 176:1139-1147.
Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S. 2002. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J. Am. Soc. Nephrol. 13:S14-S21.
Pegorier S, Campbell GA, Kay AB, Lloyd CM. 2010. Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir. Res. 11:85.
Pozdzik AA, Simon IJ, Debelle FD, Decaesteker, C, Van den Branden C, Verbeelen D, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL. 2008a. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 75:595-607.
Pozdzik AA, Simon IJ, Husson CP, Decaestecker C, Rogier E, Bourgeade MF, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL. 2008b. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol. Dial. Transplant. 23:2480-2491.
Qi X, Cai Y, Gong L, Liu L, Chen F, Xiao Y, Wu X, Li Y, Xue X, Ren J. 2007. Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid. Toxicol. Appl. Pharmacol. 222:105-110.
Rogier E, Durrbach A, Abecassis L, Ferlicot S, Snanoudj R, Baudreuil S, Arzouk N, Vazquez A, Charpentier B, Bourgeade MF. 2005. A novel biological assay to detect the active form of TGF-beta in urine to monitor renal allograft rejection. Kidney Int. 68:1875-1883.
Shirato K, Osawa H, Kaizuka M, Nakamura N, Sugawara T, Nakamura M, Tamura M, Yamabe H, Okumura K. 2003. Thrombin stimulates production of fibronectin by human proximal tubular epithelial cells via a transforming growth factor-beta-dependent mechanism. Nephrol. Dial. Transplant. 18:2248-2254.
Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R, Vanhaelen M. 1993. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341:387-391.
Vanherweghem JL, Debelle F, Muniz-Martinez MC, Nortier J. 2008. Aristolochic acid nephropathy after Chinese herbal remedies. In Clinical Nephrotoxins, 2nd edn, De Broe ME, Porter GA (eds). Kluwer Academic Publishers: Dordrecht; 579-586.
van Kooten C, Daha MR, van Es LA. 1999.Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory processes. Exp. Nephrol. 7:429-437.
Veerasamy M, Nguyen TQ, Motazed R, Pearson AL, Goldschmeding R, Dockrell ME. 2009. Differential regulation of E-cadherin and a-smooth muscle actin by BMP-7 in human renal proximal tubule epithelial cells and its implication in renal fibrosis. Am. J. Physiol. Renal Physiol. 297:F1238-F1248.
Wang S, Hirschberg R. 2003. BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells. Am. J. Physiol. Renal Physiol. 284:F1006-1013.
Wang S, Hirschberg R. 2004. Bone morphogenetic protein-7 signals opposing tranforming growth factor b in mesangial cells. J. Biol. Chem. 279:23200-23206.
Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA. 2003. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int. 63:2037-2049.
Wang Z, Zhao J, Zhang J, Wei J, Zhang J, Huang Y. 2010. Protective effect of BMP-7 against aristolochic acid-induced renal tubular epithelial cell injury. Toxicol. Lett. 198:348-357.
Xu Y, Wan J, Jiang D, Wu X. 2009. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition in human renal proximal tubular epithelial cells. J. Nephrol. 22:403-410.
Yang J, Liu Y. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159:1465-1475.
Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. 2010. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 16:535-543.
Yu MA, Shin K, Kim JH, Kim YI, Chung SS, Park SH, Kim YL, Kang DH. 2009. HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J. Am. Soc. Nephrol. 20:567-581.
Zeisberg M, Shah AA, Kalluri R. 2005. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 280:8094-8100.
